Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 18, 2009 - Issue 2
Submit an article Journal homepage
147
Views
5
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

HIF-1α inhibition as a novel mechanism of cardiac glycosides in cancer therapeutics

Evaluation of: Zhang H, Qian DZ, Tan YS, et al. Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth. Proc Natl Acad Sci USA 2008;105:19579-86

Jianqing Lin Department of Medical Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, CRBI 1M50, 1650 Orleans Street, Baltimore, Maryland, 21231, USA +1 410 614 3977; +1 410 614 3977; [email protected]
&
Michael A Carducci Department of Medical Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, CRBI 1M50, 1650 Orleans Street, Baltimore, Maryland, 21231, USA +1 410 614 3977; +1 410 614 3977; [email protected]
Pages 241-243 | Published online: 21 Jan 2009

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.